Leuven, BE, Boston, MA, US – March 31st, 2021 – 07.30 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, today announces its management will participate and meet one on one with investors at the following upcoming virtual meetings: 

• European Biotech Investor Days 2021- April 7-8, 2021 

Company Presentation, featuring Tom Graney, CFA, CFO available on demand for all registered users to view on the event’s portal. 

• 20th Annual Needham Healthcare Conference- April 14-15, 2021 

Company Presentation, featuring Tom Graney, CFA, CFO available on demand for all registered users to view on event’s portal. The webcasting link will be active for 90 days. 

• Bio€quity Europe- May 17-19, 2021 

Company Presentation, featuring Patrik De Haes, MD, CEO available on demand for all registered users to view on event’s portal.